Summit Global Investments’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,300
Closed -$216K 648
2021
Q1
$216K Buy
+3,300
New +$198K 0.01% 511
2020
Q2
Sell
-16,300
Closed -$826K 266
2020
Q1
$826K Buy
16,300
+7,000
+75% +$469K 0.12% 105
2019
Q4
$719K Buy
+9,300
New +$657K 0.08% 245
2018
Q4
Sell
-13,100
Closed -$930K 319
2018
Q3
$930K Buy
13,100
+600
+5% +$38.2K 0.12% 121
2018
Q2
$652K Buy
12,500
+500
+4% +$26.2K 0.1% 195
2018
Q1
$627K Buy
+12,000
New +$609K 0.1% 127

Other funds holding NUVA

Summit Global Investments's NUVA Position: Q2 2021 in Review

Summit Global Investments sold out of NuVasive, Inc. (NUVA) in Q2 2021, closing a stake of 3,300 shares — an estimated $216K sold.

Summit Global Investments first reported a position in NUVA in Q1 2018 and held it in 6 quarters. The position peaked at $930K in Q3 2018. 259 funds tracked by Wall St. Rank hold NUVA as of Q2 2021.

  • Summit Global Investments reported no remaining NuVasive, Inc. position as of Q2 2021 after selling out during the quarter.
  • Summit Global Investments sold 3,300 NuVasive, Inc. shares in Q2 2021, an estimated $216K.
  • Summit Global Investments first reported a position in NuVasive, Inc. in Q1 2018 and held it in 6 quarters.
  • Summit Global Investments's NuVasive, Inc. position peaked at $930K in Q3 2018.
  • 259 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2021.

Based on Summit Global Investments's 13F filing for Q2 2021, filed 28 Jan 2022.